View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Eurofins Genomics
17 March 2014

Eurofins MWG Operon Launches Ion Proton

Eurofins MWG Operon has expanded its exome sequencing services with the Ion Proton Next Generation Sequencer.

Certification for Ion AmpliSeq Exome sequencing was also awarded after joining Life Technologies Corporation’s Ion AmpliSeq Exome Certified Service Provider (CSP) programme.

Membership in Life Technologies’ CSP programme is exclusive and comprises of a select group of genomic service providers worldwide who meet the standards set by Ion Torrent for delivering high-quality sequence data.

Using Life Technologies proprietary approach, consisting of the Ion AmpliSeq Exome Kit, the Ion Proton Sequencer and Ion Reporter Software, provides researchers with the fastest, most cost-effective exome sequencing solution available with flexible throughput on the market today.

Eurofins MWG Operon vice-president Bruno Poddevin said: "Eurofins MWG Operon is pleased to gain exome certification allowing us to offer Life Technologies Ion Proton exome sequencing services to our global customers. This will further aid researchers in their quest to identify disease-causing genes."

Pharmacogenetic and pharmacogenomic analysis of the effects of pharmaceutical compounds helps to realise the concept of individualised drug therapy or personalised medicine.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology